Mycoplasmas (members of the class Mollicutes) are unique bacteria,
being the smallest, self-replicating organisms currently known.
They lack the usual cell wall outer structure of most other bacteria,
have very small amounts of genetic material (DNA), usually require
cholesterol for growth and membrane function, are filterable through
the usual bacteriological filters (450 nanometers), and are very
dependent upon the host for nutritional support. The important
mollicutes include helical wall-less prokaryotes (genus Spiroplasma)
found in some plants and many different insect hosts, the non-culturable
phytoplasmas that are plant pathogens in a variety of hosts, and
members of two genera (Mycoplasma and Ureaplasma) that most often
colonize and induce disease in vertebrate hosts. Most Mycoplasma
species are quite host specific, but exceptions occur. The oral
cavity and urogenital tract of man and animals are the most common
sites of mycoplasma colonization, with a considerable number of
species in both locations considered as normal flora.
Mycoplasma pneumoniae is an important agent in human acute respiratory
disease in children and adults, with recent evidence that Mycoplasma
fermentans might also be a respiratory pathogen in man. Ureaplasma
urealyticum and Mycoplasma hominis can be important respiratory
pathogens in human neonates. Other Mycoplasma and Ureaplasma
species are pathogenic for the respiratory tract of an ever expanding
number of domestic and wild animal hosts, including avian, bovine,
caprine, canine, equine, feline, murine, ovine, porcine, and reptilian
hosts.
Mollicutes involved in respiratory disease are inhabitants of
mucous membranes and host acquisition occurs through direct oral
to oral contact with other infected hosts. Respiratory infections
are also transferred via contact with respiratory aerosols, fomites
from infected persons or convalescent carriers. Colonization
of the respiratory tract by mycoplasmas is mediated through attachment
to host target cells, frequently involving specialized attachment
proteins (adhesins) on the organisms. This is followed by an induction
of a broad range of host immuno-regulatory events (cytokine production
and direct effects on host lymphocytes/macrophages), which may
either minimize disease through host defense mechanisms or lead
to lesion development. Host responses may vary from secondary
complications to a variety of extrapulmonary sites, to chronic
respiratory disease, or to infections with no obvious signs and
symptoms. Exacerbation of infection in a host frequently occurs
through intercurrent infections, environmental stress, or in immune
deficiencies.
Acquisition of certain pathogenic mycoplasmas into the urogenital
tract, or an increase in numbers of mycoplasmas considered as
normal flora, can have important consequences in both male and
female human or animal hosts. Infections vary from acute localized
infections (urethritis, vaginitis, pelvic inflammatory disease)
to major effects on reproductive functions (infertility) and to
intrauterine or neonatal infections.
Effective control of mycoplasma infections involves chemotherapy
with broad spectrum antibiotics (tetracyclines or macrolides)
in conjunction with a competent host immune response. Antibiotics
that inhibit bacterial cell wall synthesis (penicillin, etc.)
are not effective. Widespread chemotherapeutic approaches do not
appear to be practical in controlling mycoplasma infections in
most wild animals, and possibly in some domesticated animals.
Detection of infected hosts, through proper and effective diagnostic
procedures (cultural and serological techniques), and removal
of such hosts to confinement areas for possible treatment regimens
might be effective in some animal populations. There is little
evidence at present that such infections can be controlled through
immunization procedures.
References
Baseman, J. B., and Tully, J. G. Mycoplasmas: sophisticated,
reemerging, and burdened by their notoriety. Emerg. Infect. Diseases,
3:21-32, 1997
Tully, J. G. Mollicute-host interrelationships: current concepts
and diagnostic implications. p. 1-21. In: Molecular and Diagnostic
Procedures in Mycoplasmology, vol. 2, (ed. J. G. Tully and S.
Razin), Academic Press, San Diego, 1996.